Good morning Cough Tablets

Indications

• Digestive disorders
• Flatulence
• Bloating
• Cough relief
• Antimicrobial applications
• Sedative effects

Dosage

Children: Refer to herbal guidelines or consult a healthcare professional for specific dosing recommendations.

Adults: Refer to herbal guidelines or consult a healthcare professional for specific dosing recommendations.

Mechanism of action

The primary active compounds in anise seeds include anethole, which is responsible for the characteristic flavor and aroma. Anethole exhibits various pharmacological effects, including the modulation of neurotransmitter systems, which may contribute to its antispasmodic and carminative effects. It also has been shown to possess antioxidant properties, reducing oxidative stress in cells.

Pharmacodynamics

Anise acts as a smooth muscle relaxant, helping to alleviate gastrointestinal discomfort such as bloating and cramping. Its antimicrobial properties may help inhibit the growth of certain pathogens, contributing to its traditional use in treating digestive complaints. The sedative effects attributed to anise may provide relief from anxiety and promote sleep.

Pharmacokinetics

The pharmacokinetics of anise constituents, particularly anethole, are characterized by rapid absorption and distribution in the body. Anethole is metabolized primarily by the liver, with metabolites excreted through urine. The half-life and exact metabolism can vary between individuals, influenced by factors such as age and liver function.

Pregnancy

Safety during pregnancy has not been established. Consult a healthcare professional before use.

Breast-feeding

Consult a healthcare professional before use, as safety during breastfeeding is not well studied.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Topical pain relief for conditions such as osteoarthritis and neuropathic pain
• Management of postherpetic neuralgia
• Supportive treatment for muscle and joint pain
• Stimulation of digestion and appetite

Dosage

Children: Dosage for pediatric patients should be determined by a healthcare provider, taking into consideration

Adults: Topical formulations generally recommend application to the affected area, with specific dosing instructions provided by the product label. For oral supplements, follow the manufacturer's guidelines or consult a healthcare professional.

Mechanism of action

Capsaicin, the main active component in Capsicum, exerts its effects by binding to the TRPV1 (transient receptor potential vanilloid 1) receptor, which is a cation channel involved in the transmission of pain and heat sensations. This binding leads to the depolarization of sensory neurons, resulting in the release of substance P, a neuropeptide associated with pain signaling. Continuous exposure to capsaicin results in the desensitization of these receptors, leading to decreased pain perception over time.

Pharmacodynamics

The analgesic properties of Capsicum are attributed to its ability to alter the perception of pain. Capsaicin induces a sensation of warmth and pain initially, which is followed by a prolonged analgesic effect due to the depletion of substance P from the nerve endings. Additionally, Capsicum may exhibit anti-inflammatory effects through the modulation of cytokine release and inhibition of inflammatory pathways, contributing to its therapeutic applications in pain management and inflammatory conditions.

Pharmacokinetics

Capsaicin is poorly absorbed when ingested orally, but it can be effectively absorbed through the skin when applied topically. After application, it is metabolized by the liver, and its metabolites are excreted primarily through the kidneys. The onset of action for topical preparations can vary, with effects often observed within hours. The duration of action may last from several hours to days, depending on the formulation and the area of application.

Adverse effects

• Burning sensation at the site of application
• Skin irritation or rash
• Gastrointestinal upset (if ingested)
• Allergic reactions

Precautions

• Avoid contact with eyes and mucous membranes
• Use caution in patients with sensitive skin
• Consult a healthcare professional before use in patients with underlying health conditions

Pregnancy

Capsicum is generally considered unsafe during pregnancy due to potential effects on the fetus. Pregnant women should consult a healthcare provider before use.

Breast-feeding

Capsicum should be used with caution during breastfeeding as it may affect milk production or flavor.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Topical ointments or creams
• Capsules
• Powdered form for oral use

Indications

• Respiratory infections
• Cough and cold symptoms
• Sinusitis
• Bronchitis
• Muscle pain and inflammation

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil in children, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing of eucalyptus oil, as it varies based on formulation and indication.

Mechanism of action

Eucalyptus oil contains compounds such as eucalyptol (1,8-cineole) that exhibit antimicrobial properties. It acts on the respiratory system by promoting bronchodilation and reducing mucus production. The oil also has a cooling effect, which can provide relief from symptoms of respiratory distress. Additionally, the oil's anti-inflammatory properties help decrease inflammation in the airways.

Pharmacodynamics

The primary active ingredient in eucalyptus oil, eucalyptol, interacts with the body's inflammatory response and can modulate the activity of neurotransmitters involved in pain signaling. It may enhance mucociliary clearance in the respiratory tract, facilitating the expulsion of mucus and pathogens. The analgesic effects can help relieve discomfort associated with respiratory infections.

Pharmacokinetics

Eucalyptus oil is typically administered via inhalation or topical application. When inhaled, components like eucalyptol are absorbed through the mucous membranes of the respiratory tract and rapidly distributed throughout the body. The oil is metabolized primarily in the liver, and its metabolites are excreted in urine. The half-life of eucalyptol varies but is generally short, necessitating frequent dosing for sustained effects.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Diarrhea
• Dizziness

Interactions

• May interact with anticoagulants, potentially increasing bleeding risk
• May enhance the effects of other medications that cause sedation

Precautions

• Use with caution in individuals with asthma or other respiratory conditions
• Avoid use in young children without medical supervision
• Eucalyptus oil should not be ingested in large quantities due to toxicity

Pregnancy

Eucalyptus oil is generally considered unsafe in pregnancy due to potential toxicity and should be avoided unless prescribed by a healthcare professional.

Breast-feeding

Caution is advised when using eucalyptus during breastfeeding, as it may pass into breast milk and could affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Eucalyptus oil (topical, inhalation, or oral preparations)
• Eucalyptus leaves (dried for teas or extracts)

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Mild to moderate pain
• Acute pain conditions
• Inflammatory disorders

Dosage

Children: Refer to specific clinical guidelines or the BNF for Children for appropriate dosing.

Adults: Refer to specific clinical guidelines or the official BNF for appropriate dosing.

Mechanism of action

Kreostum exerts its effects by inhibiting the enzyme cyclooxygenase (COX), which is responsible for the conversion of arachidonic acid to prostaglandins. By blocking this pathway, Kreostum reduces the levels of prostaglandins, thereby alleviating pain and inflammation. The drug may also exhibit some degree of analgesic activity through central mechanisms in the central nervous system.

Pharmacodynamics

The pharmacodynamic effects of Kreostum are primarily related to its anti-inflammatory and analgesic properties. It reduces pain associated with various conditions by decreasing the inflammatory response. The onset of action typically occurs within one to two hours after administration, with peak effects observed within several hours. The overall effectiveness varies among individuals due to factors such as the severity of the condition and the presence of other comorbidities.

Pharmacokinetics

Kreostum is well absorbed from the gastrointestinal tract, with peak plasma concentrations achieved within a few hours post-ingestion. It has a half-life of approximately 2 to 4 hours, depending on individual metabolic factors. The drug is extensively metabolized in the liver, primarily via cytochrome P450 enzymes, and its metabolites are excreted primarily in the urine. Renal function can influence the clearance of the drug, necessitating caution in patients with renal impairment.

Pregnancy

Kreostum should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as safety in pregnancy has not been established.

Breast-feeding

It is not known whether kreostum is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, protected from light. Keep out of reach of children.

Indications

• Insecticide for agricultural use
• Research tool in toxicology

Dosage

Children: Refer to the BNF for Children for specific dosing and administration guidelines.

Adults: Refer to the BNF for specific dosing and administration guidelines.

Mechanism of action

Methyl parathion acts primarily by inhibiting the enzyme acetylcholinesterase, which is essential for the breakdown of the neurotransmitter acetylcholine. Its active metabolite, methyl paraoxon, is a potent inhibitor of both acetylcholinesterase and butyrylcholinesterase. The inhibition of these enzymes results in the accumulation of acetylcholine at synapses, leading to overstimulation of cholinergic receptors and resultant toxic effects.

Pharmacodynamics

The pharmacodynamics of methyl parathion involve its action as a noncompetitive inhibitor of acetylcholinesterase, causing prolonged effects of acetylcholine due to its inability to be hydrolyzed. The resultant cholinergic toxicity can lead to symptoms such as muscle twitching, respiratory distress, and potentially fatal outcomes if not treated promptly. The extent of inhibition is dose-dependent, with significant toxicity occurring after substantial enzyme inhibition.

Pharmacokinetics

Methyl parathion is absorbed through the gastrointestinal tract and can also be absorbed through the skin and respiratory tract. It is metabolized in the liver to form methyl paraoxon, which is responsible for the majority of its toxic effects. The distribution of methyl parathion in body tissues is influenced by its lipophilicity, and it is primarily excreted as metabolites in the urine. The elimination half-life and specific pharmacokinetic parameters can vary based on individual metabolism and exposure levels.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution is advised when administering to nursing women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Liquid formulation

Indications

• Digestive upset
• Nausea
• Headache
• Topical pain relief
• Respiratory congestion

Dosage

Children: Refer to specific product guidelines for dosing, as it varies based on formulation and indication.

Adults: Refer to specific product guidelines for dosing, as it varies based on formulation and indication.

Mechanism of action

The primary active ingredient in menthe is menthol, which interacts with the TRPM8 receptor, a cold and menthol receptor in the sensory neurons, leading to a sensation of cooling. Additionally, menthol has a mild analgesic effect, which can help alleviate pain. It may also have antispasmodic properties that aid in digestive issues.

Pharmacodynamics

Menthol exhibits various pharmacodynamic effects, including the stimulation of cold receptors in the skin and mucous membranes, leading to a cooling sensation. This can provide relief from minor aches and pains when applied topically. Moreover, menthe has been shown to have mild antimicrobial properties, which can contribute to its use in oral hygiene products.

Pharmacokinetics

Menthol is rapidly absorbed through the gastrointestinal tract and metabolized in the liver. It has a relatively low volume of distribution and is primarily excreted in the urine as conjugated metabolites. The onset of action for its topical applications can be immediate, while oral ingestion may have a delayed effect depending on the dosage form.

Adverse effects

• Allergic reactions
• Dermatitis
• Gastrointestinal disturbances
• Headache
• Heartburn

Precautions

• Use with caution in patients with a history of allergies to mint or related plants
• May cause irritation if applied topically to broken skin
• Use with caution during pregnancy and lactation

Pregnancy

Mentha species are generally considered safe in food amounts during pregnancy, but medicinal use should be approached with caution due to limited safety data.

Breast-feeding

Mentha species are generally regarded as safe in food amounts during breastfeeding, but caution is advised with medicinal use due to limited data.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Essential oil
• Infusion
• Extract
• Topical ointment

Indications

• Topical analgesic for muscle and joint pain
• Cough suppressant in cough drops and lozenges
• Relief of minor throat irritation
• Cooling agent in various cosmetic and personal care products

Dosage

Children: Refer to BNF for Children for specific dosing guidelines, as doses may vary based on age and formulation.

Adults: For topical use, apply a thin layer to the affected area not more than 3 to 4 times daily. For cough drops, follow the product-specific instructions as per the formulation.

Mechanism of action

Menthol acts as an agonist for the transient receptor potential subtype M8 (TRPM8), a non-selective cation channel that is activated by cold temperatures. This activation leads to calcium influx in mast cells, inducing the release of histamine, which can trigger allergic responses such as urticaria, asthma, and rhinitis. Menthol's ability to induce histamine release via TRPM8 suggests potential therapeutic applications for TRPM8 antagonists in managing cold- and menthol-induced allergies.

Pharmacodynamics

Menthol produces a cooling effect by stimulating sensory neurons that convey cold sensations. It interacts with TRPM8 channels, leading to the activation of intracellular signaling pathways that can result in vasodilation and increased blood flow to the area of application. This cooling sensation can provide symptomatic relief in conditions characterized by pain or irritation.

Pharmacokinetics

Menthol is absorbed through the skin and mucous membranes, with systemic effects depending on the route of administration. Its bioavailability can vary, and it is metabolized primarily in the liver. The elimination half-life and excretion pathways have not been extensively characterized, but menthol is generally considered to have a rapid onset of action with effects lasting for a few hours.

Adverse effects

• Allergic reactions
• Urticaria
• Asthma
• Rhinitis
• Skin irritation

Precautions

• Use with caution in patients with known allergies to menthol or related compounds
• May exacerbate asthma in sensitive individuals

Pregnancy

There are no well-controlled studies of menthol in pregnant women. Menthol should be used during pregnancy only if clearly needed.

Breast-feeding

Menthol is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Topical ointment
• Cream
• Liquid

Dosage

Children: Oleum is not used for therapeutic dosing in children.

Adults: Oleum is not used for therapeutic dosing in adults.

Mechanism of action

Oleum acts primarily as a strong acid and dehydrating agent. Upon contact with water, it forms sulfuric acid, which dissociates to release protons (H+), leading to acidification. The presence of sulfur trioxide enhances its reactivity, enabling it to sulfonate organic compounds, thus modifying their chemical properties and reactivity.

Pharmacodynamics

Oleum's pharmacodynamics are rooted in its ability to react with water and organic substrates. The release of protons contributes to its acidic properties, while the sulfonation process allows it to interact with biomolecules, potentially altering their function. However, oleum is not used therapeutically due to its extreme toxicity and corrosiveness.

Pharmacokinetics

Oleum does not have a pharmacokinetic profile as it is not administered as a drug for therapeutic purposes. Its use is limited to industrial applications, and it is handled with extreme caution due to its corrosive nature. Exposure can occur via inhalation, dermal contact, or ingestion, leading to severe chemical burns and respiratory damage.

Pregnancy

There is limited information on the safety of oleum during pregnancy. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Due to insufficient data, the use of oleum during breastfeeding should be approached with caution. Weigh the risks and benefits before use.

Storage

Store in a cool, dry place away from direct sunlight and moisture. Ensure containers are tightly sealed to prevent contamination.

Indications

• Digestive issues such as bloating and gas
• Irritable bowel syndrome (IBS)
• Headaches and migraines
• Nausea
• Muscle pain or discomfort
• Respiratory conditions such as sinusitis

Dosage

Children: Refer to the BNF for Children for dosing recommendations, as pediatric dosages are based on age, weight, and specific health conditions.

Adults: Refer to established guidelines and product-specific instructions for appropriate dosing, as it can vary based on the formulation and indication.

Mechanism of action

The primary active component of peppermint, menthol, produces a cooling effect by activating TRPM8 receptors, which are responsible for sensing temperature changes. This mechanism leads to vasodilation and a sensation of cooling on the skin and mucous membranes. Additionally, menthol may exert antispasmodic effects on the gastrointestinal tract, helping to alleviate symptoms of digestive discomfort.

Pharmacodynamics

Peppermint exhibits a range of pharmacodynamic effects, including muscle relaxation in the gastrointestinal tract, which may help to reduce cramping and spasm. Its analgesic properties can provide symptomatic relief from headaches and migraines when applied topically. The aromatic properties of peppermint also have a calming effect, which can contribute to its use in treating nausea and anxiety.

Pharmacokinetics

Peppermint oil is rapidly absorbed when administered orally or topically. Following oral administration, menthol is metabolized primarily in the liver through glucuronidation. The half-life of menthol is approximately 1.5 hours, with metabolites excreted in urine. When applied topically, menthol's effects are localized, with minimal systemic absorption. The onset of action can vary depending on the route of administration, with topical applications typically providing rapid relief.

Adverse effects

• allergic reactions
• gastrointestinal disturbances
• heartburn
• nausea
• vomiting

Interactions

• may interact with anticoagulants
• may affect the metabolism of certain medications due to cytochrome P450 enzymes

Precautions

• use with caution in individuals with gastroesophageal reflux disease (GERD)
• consider potential for allergic reactions in sensitive individuals

Pregnancy

Generally considered safe in culinary amounts, but high doses should be avoided due to lack of sufficient safety data.

Breast-feeding

Generally considered safe in culinary amounts, but high doses should be avoided due to lack of sufficient safety data.

Storage

Store in a cool, dry place away from direct light.

Formulations

• essential oil
• dried leaves
• herbal teas
• capsules

Dosage

Children: Refer to specific product information based on the active ingredient present in the pulvis formulation.

Adults: Refer to specific product information based on the active ingredient present in the pulvis formulation.

Mechanism of action

The mechanism of action for pulvis depends on its active ingredients. Generally, powders facilitate the delivery of medications that may act through various pathways, including receptor binding, enzyme inhibition, and modulation of physiological processes. Each powder formulation will have a unique profile based on its constituents.

Pharmacodynamics

Pharmacodynamics of pulvis is contingent upon the active substances it contains. Typically, these substances exhibit a range of effects, from anti-inflammatory to analgesic properties. The efficacy of the powder is influenced by its bioavailability, the pharmacological activity of its ingredients, and the method of administration.

Pharmacokinetics

The pharmacokinetics of pulvis is variable and depends on the specific active ingredient. Generally, upon administration, the powder is absorbed through the gastrointestinal tract or skin, depending on the intended route. The distribution, metabolism, and excretion will vary with each substance, influencing the onset and duration of action.

Pregnancy

The safety of pulvis during pregnancy has not been established. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

Caution is advised when administering pulvis to breastfeeding mothers, as the effects on nursing infants are not well documented.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Herbal remedy for anxiety
• Support for digestive health
• Anti-inflammatory support
• Antimicrobial effects
• Pain relief
• Support for immune function

Dosage

Children: Refer to specific tincture product instructions for dosage, as this varies significantly based on the plant and concentration.

Adults: Refer to specific tincture product instructions for dosage, as this varies significantly based on the plant and concentration.

Mechanism of action

The mechanism of action of tinctures depends on the specific herbs or plants used in their preparation. Generally, the active compounds extracted from the plant material interact with various biological pathways, including receptor modulation, enzyme inhibition, and antioxidant activity. For example, flavonoids and alkaloids found in many tinctures may exhibit anti-inflammatory, analgesic, or antimicrobial effects through their interaction with cellular signaling pathways.

Pharmacodynamics

The pharmacodynamics of tinctures is influenced by the specific constituents of the herbal material. These constituents may exert effects such as enhancing or inhibiting neurotransmitter activity, modulating inflammatory responses, or influencing metabolic pathways. The effects can vary widely among different tinctures based on the plant used, the extraction method, and the concentration of the active ingredients.

Pharmacokinetics

The pharmacokinetics of tinctures involves absorption, distribution, metabolism, and excretion of the active compounds. After administration, the alcohol or vinegar solvent aids in the rapid absorption of these compounds through the mucosal membranes or gastrointestinal tract. Once absorbed, the compounds are distributed throughout the body and may undergo metabolic transformations primarily in the liver. The elimination half-life varies based on the specific herb and its active constituents, with some compounds being excreted unchanged while others are metabolized into active or inactive metabolites.

Contra-indications

• Hypersensitivity to any component of the tincture
• Severe liver disease
• Pregnancy (specific tinctures may vary)

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal upset
• Drowsiness or sedation (depending on the active ingredient)

Interactions

• May interact with alcohol, increasing sedative effects
• Potential interactions with other CNS depressants
• May affect the metabolism of certain drugs via hepatic pathways

Precautions

• Use cautiously in patients with a history of substance abuse
• Monitor liver function in patients with liver disease
• Caution in operating machinery or driving due to potential drowsiness

Pregnancy

Generally not recommended during pregnancy due to potential risks associated with alcohol and other active ingredients.

Breast-feeding

Caution is advised, as components may pass into breast milk and affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Formulations

• Tinctures of various herbs and compounds, including but not limited to: echinacea, valerian, and calendula

Dosage

Children: There are no established therapeutic doses for toluene in the pediatric population. Exposure should be avoided due to potential toxicity.

Adults: There are no established therapeutic doses for toluene as it is primarily used as an industrial solvent. Exposure should be minimized due to its toxic effects.

Mechanism of action

Toluene exerts its effects primarily through its interaction with the central nervous system. It acts as a neurotoxin and can influence neurotransmitter systems, particularly those involving gamma-aminobutyric acid (GABA) and glutamate. The exact pathways are not fully elucidated, but toluene is known to enhance GABAergic activity, leading to sedative and anxiolytic effects, while also disrupting glutamate signaling, which can contribute to neurotoxicity.

Pharmacodynamics

The pharmacodynamics of toluene involve its effects on the central nervous system, where it can lead to a range of symptoms from euphoria and intoxication to neurological impairment and respiratory depression at higher exposures. Chronic exposure may result in neurobehavioral deficits, cognitive dysfunction, and potential long-term neurological damage. The effects can vary significantly based on concentration, duration of exposure, and individual susceptibility.

Pharmacokinetics

Toluene is rapidly absorbed through inhalation and dermal routes, with peak blood concentrations occurring shortly after exposure. It is metabolized primarily in the liver via cytochrome P450 enzymes, leading to the formation of various metabolites, including benzyl alcohol and hippuric acid. These metabolites are excreted in the urine. The elimination half-life of toluene varies depending on the route of exposure and individual metabolic factors, generally ranging from a few hours to a day.

Pregnancy

Toluene is not recommended during pregnancy due to potential risks to fetal development. It may cause teratogenic effects.

Breast-feeding

Toluene may be excreted in breast milk, and its use is generally not recommended while breastfeeding due to potential harm to the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight, heat, and ignition sources. Ensure containers are tightly sealed.

Mechanism of action

Acute poisoning ... is related to ... inhibiting action on enzyme acetylcholinesterase. Toxic manifestations generally occur only after more than 50% of plasma cholinesterase is inhibited. ... Methyl parathion ... depend on oxidative activation by replacement of thiono-sulfur with oxygen for ... toxicity. Methyl parathion has only a slight inhibitory action on acetylcholinesterase and butyrylcholinesterase, but its active metabolite, methyl paraoxon, is a potent inhibitor of both these enzymes. A study was conducted examining the inhibition of (Ca2+ and Mg2+)-ATPase by parathion (56382) and methyl parathion. Enzyme activity was assessed spectrophotometrically in pig erythrocyte membranes containing calcium2+ (Ca2+) and magnesium2+ and in solubilized membrane preparations incubated with the test agents. The enzyme response to ATP was biphasic. Equations expressing the kinetics of the substrate curves described two classes of the ATP binding active site, one with high affinity and low maximum rate and one with low affinity and high maximum rate. High affinity active sites were stimulated by low ATP concentrations (20 uM), whereas low affinity active sites were stimulated by high ATP levels (2 mM). Parathion and methylparathion dose dependently inhibited enzyme activity; parathion had a greater inhibitory effect than methylparathion. Lineweaver-Burke and Dixon plots indicated noncompetitive inhibition. Parathion and methylparathion induced enzyme inhibition occurred over a range of free calcium ion concentrations (0.5 to 5 mM); the inhibition was significantly greater at lower Ca2+ concentrations (1 to 100 uM) than at higher concentrations. The authors conclude that parathion and methylparathion inhibit ATPase activity by binding to a site on the enzyme rather than through an interaction with associated lipids. For more Mechanism of Action (Complete) data for METHYL PARATHION (6 total), please visit the HSDB record page.

Mechanism of action

Exposure to low temperatures often causes allergic responses or urticaria. Similarly, menthol, a common food additive is also known to cause urticaria, asthma, and rhinitis. However, despite the obvious clinical implications, the molecular mechanisms responsible for inducing allergic responses to low temperatures and menthol have not been determined. Because a non-selective cation channel, transient receptor potential subtype M8 (TRPM8) is activated by cold and menthol, we hypothesized that this channel mediates cold- and menthol-induced histamine release in mast cells. Here, we report that TRPM8 is expressed in the basophilic leukemia mast cell line, RBL-2H3, and that exposure to menthol or low temperatures induced Ca(2+) influx in RBL-2H3 cells, which was reversed by a TRPM8 blocker. Furthermore, menthol, a TRPM8 agonist, induced the dose-dependent release of histamine from RBL-2H3 cells. When TRPM8 transcripts were reduced by siRNA (small interfering RNA), menthol- and cold-induced Ca(2+) influx and histamine release were significantly reduced. In addition, subcutaneous injection of menthol evoked scratching, a typical histamine-induced response which was reversed by a TRPM8 blocker. Thus, our findings indicate that TRPM8 mediates the menthol- and cold-induced allergic responses of mast cells, and suggest that TRPM8 antagonists be viewed as potential treatments for cold- and menthol-induced allergies. /DL-Menthol/ Menthol's characteristic cooling sensation is due, in part, to the activation of sensory neurons generally termed transient receptor potential (TRP) channels, in particular transient receptor potential melastatin family member 8 (TRPM8) and transient receptor potential subfamily A, member 1 (TRPA1). Menthol acts upon TRPM8 receptors by rapidly increasing intracellular calcium and mobilizing calcium flux through the channels to induce cold response signals at the application site. Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia. /DL-Menthol/ In recent years, the transient receptor potential melastatin member 8 (TRPM8) channel has emerged as a promising prognostic marker and putative therapeutic target in prostate cancer. We have found that forced overexpression of TRPM8 in PC-3 cells can inhibit the cell proliferation and motility probably through the TRPM8 activation. In this study, we aimed to investigate whether activating the TRPM8 channel by its selective agonist menthol can inhibit the proliferation and motility of androgen-independent prostate cancer (AIPC) with remarkable expression of TRPM8. Menthol is a naturally occurring compound, which has been widely used in cosmetics and pharmaceutical products, and also as flavoring in food. DU145 cells are androgen-independent but have a remarkable expression of TRPM8. The demonstration of the existence of TRPM8 and the absence of TRPA1 in DU145 cells provided the foundation for the following experiments, because both TRPM8 and TRPA1 are molecular targets of menthol. The outcome of MTT assay indicated that menthol inhibited the cell growth (p < 0.01). Cell cycle distribution and scratch assay analysis revealed that menthol induced cell cycle arrest at the G(0)/G(1) phase (p < 0.01). Furthermore, menthol inhibited the migration of DU145 cells by downregulating the focal-adhesion kinase. So it suggests that the activation of the existing TRPM8 channels may serve as a potential and pragmatic treatment for those AIPC with remarkable expression of TRPM8, and menthol is a useful compound for future development as an anticancer agent. /DL-Menthol/